FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation
Jie Xu(Cornell University), Gabriel Núñez(Michigan Center for Translational Pathology), Joseph M. Pickard(University of Michigan)
Cited by 49
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
|Immunological Reviews|2017|1.7k
Mechanisms of inflammation-driven bacterial dysbiosis in the gut
|Mucosal Immunology|2016|864
Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA
|Journal of Biological Chemistry|2006|698